1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ANIMAL BIOTECHNOLOGY MARKET, BY PRODUCT
5.1. Introduction
5.2. Diagnostic Tests
5.3. Vaccines
5.4. Drugs
5.5. Reproductive and Genetic
5.6. Feed Additives
6. ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION
6.1. Introduction
6.2. Diagnosis of Animal Disease
6.3. Treatment of Animal Disease
6.4. Preventive Care of Animals
6.5. Drug Development
6.6. Others
7. ANIMAL BIOTECHNOLOGY MARKET, BY END-USE
7.1. Introduction
7.2. Laboratories
7.3. In-house Testing
7.4. Clinics
7.5. Others
8. ANIMAL BIOTECHNOLOGY MARKET, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Zeus Biotech Pvt. Ltd.
10.2. Invetx
10.3. Ingenta Connect
10.4. Kingfisher Biotech
10.5. Animab
10.6. Boehringer Ingelheim
10.7. Beveridge & Diamond PC
10.8. RSPCA
10.9. Santa Cruz Biotechnology
10.10. Pfizer